Home | Articles
Published on:June 2022
Indian Journal of Pharmaceutical Education and Research, 2022; 56(3):628-635
Review Article | doi:10.5530/ijper.56.3.111

Therapeutic Approaches of Nanotechnology for Epileptic Seizures: A Comprehensive Review of Current Knowledge


Authors and affiliation (s):

Aman Shrivastava1,*, Jeetendra K Gupta1, Manoj K Goyal2

1Department of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, INDIA.

2Jai Institute of Pharmaceutical Sciences and Research, Gwalior, Madhya Pradesh, INDIA.

Abstract:

Epilepsy is a chronic neurological condition in which several neurotransmitters act like neuromodulators. The symptoms of epilepsy are caused by abnormal electrical discharges in a group of neurons in the hippocampus region of the brain. This can also affect electrical impulse generation, either in the focal area or in the hippocampus region of the brain. This review aimed to develop a better understanding of the transportation of nanoparticles across the blood-brain barrier and how to enhance the delivery of the drug in epileptic conditions by the utilization of nanomaterials. A few clinical studies have reported that antiepileptic drugs are generally used for the treatment of epilepsy by decreasing the frequency and intensity of seizures or preventing tissue damage in the brain. In longterm therapy, antiepileptic drugs are primarily administered via the oral route, but they are not always beneficial. Therefore, intravenous routes are especially used in serious epileptic conditions. In this review, we discussed the drug delivery study of antiepileptic drugs that are used in the form of nanoparticles that can easily be transported across the blood-brain barrier. Besides, the nanoparticles can easily cross the blood-brain barrier and increase the uptake into the target cells. Drug absorption into the brain is substantially limited by some factors, especially in the blood-brain barrier, which affects the potency of antiepileptic drugs to reach and remain inside the brain. Novel drug delivery systems have already been studied in many clinical trials to enhance the therapeutic efficacy of antiepileptic drugs in epileptic conditions.

Keywords: Epilepsy, Nanotechnology, Drug delivery, Movement of nanoparticle, Neurodegenerative disorder.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2021 Journal Citation Reports® (Clarivate Analytics, 2022): 0.843

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs